ALKS - Alkermes Inc. plc

ALKS

$39.95 0.31 (-0.77%) Last updated: Oct 13, 2026 19:49

52-Week Range

$39.95

$27.00 $39.95 $55.67

Fundamentals Overview

Alkermes Inc. plc is in the middle of its 52-week range with premium valuation, trading relatively flat today.

Valuation premium

P/E 103 P/B 4.83 P/S 4.09

Profitability

ROE 3.72% Net margin 4%

Risk (Beta)

0.25 — lower vol

BullzEye Analysis

Our composite tilts Hold on technicals (e.g. RSI, ADX, trend), fundamentals, sentiment, sector and index context, and risk.

Composite Signal

Sell

Buy

Hold — 57% confidence Risk: Lower Volatility — Beta 0.25. Diversify and only invest what you can afford to lose.

Pressures (Sell):

P/E 103 (premium) · Volume below average

Not financial advice. For education and research only; do your own research and consider a financial advisor before investing.

Key Stats

Market Cap

$6.75B

P/E (TTM)

103.03

EPS (TTM)

N/A

Dividend Yield

N/A

52-Week Range

$27.00 - $55.67

Volume vs Avg

0.24x

24% of avg (Low)

Beta

0.25

About

Alkermes PLC is a fully integrated biotechnology company that applies its proprietary technologies to research, develop, and commercialize pharmaceutical products designed for unmet medical needs in therapeutic areas. The company utilizes several to develop and commercialize products and, in so doing, access technological, financial, marketing, manufacturing, and other resources. Alkermes either purchases active drug products from third parties or receives them from its third-party licensees to ...

Sector: Healthcare

Headquarters: IE

Website: www.alkermes.com

Beta: 0.25 (Less volatile than market)

Financial story & AI narrative

Open this tab to load the financial story.

Valuation & Ratios

Valuation, liquidity, and profitability metrics are consolidated here (including ratios that previously appeared in the Financials story). Trailing (TTM) vs forward-looking (e.g. DCF) is noted on each line where it matters.

Metric	Value
Valuation
P/E (TTM)	103.03
PEG (TTM)	N/A
P/B (TTM)	4.83
P/S (TTM)	4.09
Profitability
ROE (TTM)	3.72%
ROA (TTM)	1.96%
Revenue growth (YoY)	N/A
Net margin (TTM)	3.97%
Gross margin (TTM)	84.56%
Operating margin (TTM)	7.03%
Debt to equity (TTM)	0.83

Latest News

News loads when you open this tab.

Price Target, Ratings & Grades

Analyst price targets, consensus, rating snapshot, and institutional grades for ALKS.

Loading analyst coverage...

Price target data is not available for this symbol from the current data source.

Stock Grades (Institutions)

No stock grades available for this symbol.

No price targets, ratings snapshot, or grades available for this symbol.